Glenmede Trust’s RELYPSA INC COM RLYP Stock Holding History

Glenmede Trust’s Portfolio RLYP Stock Details RLYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,304	Closed	-$40K	–	2624
2014 Q4	$40K	Buy	+1,304	New	+$31K	﹤0.01%	1820

Other funds holding RLYP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Trust's RLYP Position: Q1 2015 in Review

Glenmede Trust sold out of RELYPSA INC COM (RLYP) in Q1 2015, closing a stake of 1,304 shares — an estimated $40K sold.

Glenmede Trust first reported a position in RLYP in Q4 2014 and held it in 1 quarter. The position peaked at $40K in Q4 2014. 122 funds tracked by Wall St. Rank hold RLYP as of Q1 2015.

Glenmede Trust reported no remaining RELYPSA INC COM position as of Q1 2015 after selling out during the quarter.
Glenmede Trust sold 1,304 RELYPSA INC COM shares in Q1 2015, an estimated $40K.
Glenmede Trust first reported a position in RELYPSA INC COM in Q4 2014 and held it in 1 quarter.
Glenmede Trust's RELYPSA INC COM position peaked at $40K in Q4 2014.
122 funds tracked by Wall St. Rank held RELYPSA INC COM as of Q1 2015.

Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.